1. Home
  2. TECH vs SNN Comparison

TECH vs SNN Comparison

Compare TECH & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

N/A

Current Price

$72.68

Market Cap

11.4B

Sector

Health Care

ML Signal

N/A

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

N/A

Current Price

$30.18

Market Cap

12.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TECH
SNN
Founded
1976
1856
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.4B
12.3B
IPO Year
1995
2002

Fundamental Metrics

Financial Performance
Metric
TECH
SNN
Price
$72.68
$30.18
Analyst Decision
Hold
Hold
Analyst Count
13
6
Target Price
★ $70.50
$32.32
AVG Volume (30 Days)
★ 2.7M
1.2M
Earning Date
11-17-2026
08-04-2026
Dividend Yield
0.44%
★ 2.53%
EPS Growth
★ 152.17
N/A
EPS
★ 1.16
N/A
Revenue
★ $1,215,039,000.00
N/A
Revenue This Year
$4.38
$4.75
Revenue Next Year
$10.06
$5.15
P/E Ratio
★ $62.65
$64.97
Revenue Growth
N/A
★ N/A
52 Week Low
$43.20
$26.30
52 Week High
$72.75
$37.09

Technical Indicators

Market Signals
Indicator
TECH
SNN
Relative Strength Index (RSI) 57.86 61.82
Support Level $72.11 $29.18
Resistance Level $72.75 $30.52
Average True Range (ATR) 0.11 0.47
MACD -0.00 0.08
Stochastic Oscillator 80.00 62.64

Price Performance

Historical Comparison
TECH
SNN

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: